S
Sharmistha Mishra
Researcher at University of Toronto
Publications - 199
Citations - 3100
Sharmistha Mishra is an academic researcher from University of Toronto. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 24, co-authored 156 publications receiving 2156 citations. Previous affiliations of Sharmistha Mishra include World Health Organization & St. Michael's GAA, Sligo.
Papers
More filters
Report 12: The global impact of COVID-19 and strategies for mitigation and suppression
Patrick G T Walker,Charles Whittaker,Oliver J Watson,Marc Baguelin,Kylie E. C. Ainslie,Sangeeta N. Bhatia,Samir Bhatt,A Boonyasiri,Olivia Boyd,Lorenzo Cattarino,Z Cucunuba Perez,Gina Cuomo-Dannenburg,Amy Dighe,Christl A. Donnelly,Ilaria Dorigatti,S Van Elsland,Richard G. FitzJohn,Seth Flaxman,Han Fu,Katy A. M. Gaythorpe,Lily Geidelberg,Nicholas C. Grassly,W Green,Arran Hamlet,Katharina Hauck,D Haw,Sarah Hayes,Wes Hinsley,Natsuko Imai,David Jorgensen,Edward Knock,Daniel J Laydon,Sharmistha Mishra,G Nedjati Gilani,Lucy C Okell,Steven Riley,H Thompson,H Unwin,Robert Verity,Michaela A. C. Vollmer,Caroline E. Walters,Haowei Wang,Y Wang,Peter Winskill,Xiaoyue Xi,Neil M. Ferguson,Azra C. Ghani +46 more
TL;DR: Patrick GT Walker*, Charles Whittaker*, Oliver Watson, Marc Baguelin, Kylie E C Ainslie, Sangeeta Bhatia, Samir Bhatt, Adhiratha Boonyasiri, Olivia Boyd, Lorenzo Cattarino, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Christl A Donnelly, Ilaria Dorigatti, Sabine van Elsland, Rich FitzJohn.
Journal ArticleDOI
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models
Jeffrey W. Eaton,Nicolas A Menzies,John Stover,Valentina Cambiano,Leonid Chindelevitch,Anne Cori,Jan A. C. Hontelez,Jan A. C. Hontelez,Jan A. C. Hontelez,Salal Humair,Cliff C. Kerr,Daniel J. Klein,Sharmistha Mishra,Sharmistha Mishra,Kate M. Mitchell,Brooke E Nichols,Peter Vickerman,Roel Bakker,Till Bärnighausen,Till Bärnighausen,Anna Bershteyn,David E. Bloom,Marie-Claude Boily,Stewart T. Chang,Ted Cohen,Ted Cohen,Peter J. Dodd,Christophe Fraser,Chaitra Gopalappa,Jens D Lundgren,Jens D Lundgren,Natasha K. Martin,Natasha K. Martin,Evelinn Mikkelsen,Elisa Mountain,Quang D. Pham,Michael Pickles,Andrew N. Phillips,Lucy Platt,Carel Pretorius,H Prudden,Joshua A. Salomon,David A. M. C. van de Vijver,Sake J. de Vlas,Bradley G. Wagner,Richard G. White,David Wilson,Lei Zhang,John M. Blandford,Gesine Meyer-Rath,Gesine Meyer-Rath,Michelle Remme,Paul Revill,Nalinee Sangrujee,Fern Terris-Prestholt,Meg Doherty,Nathan Shaffer,Philippa Easterbrook,Gottfried Hirnschall,Timothy B. Hallett +59 more
TL;DR: Estimates suggest that earlier eligibility for antiretroviral therapy is very cost effective in low-income and middle-income settings, although these estimates should be revisited when more data become available.
Journal ArticleDOI
Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.
John G. Mattia,Mathew J Vandy,Joyce Chang,Devin Platt,Kerry Dierberg,Daniel G. Bausch,Tim Brooks,Sampha Conteh,Ian Crozier,Ian Crozier,Robert A. Fowler,Robert A. Fowler,Amadu Kamara,Cindy Kang,Srividya Mahadevan,Yealie Mansaray,Lauren Marcell,Gillian McKay,Tim O'Dempsey,Tim O'Dempsey,Victoria Parris,Ruxandra Pinto,Audrey Rangel,Alex P. Salam,Jessica G. Shantha,Vanessa Wolfman,Steven Yeh,Adrienne K. Chan,Adrienne K. Chan,Adrienne K. Chan,Sharmistha Mishra,Sharmistha Mishra +31 more
TL;DR: The findings underscore the need for early clinical follow-up of survivors of EVD and urgent provision of ocular care as part of health systems strengthening in EVD-affected west African countries.
Journal ArticleDOI
Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis
Elisa Mountain,Sharmistha Mishra,Peter Vickerman,Michael Pickles,Charles F. Gilks,Marie-Claude Boily +5 more
TL;DR: It is suggested that FSWs can achieve levels of ART uptake, retention, adherence, and treatment response comparable to that seen among women in the general population, but these data are from only a few research settings.
Journal ArticleDOI
Ebola virus disease and critical illness
Aleksandra Leligdowicz,William A. Fischer,Timothy M. Uyeki,Tom Fletcher,Tom Fletcher,Neill K. J. Adhikari,Neill K. J. Adhikari,Gina Portella,Francois Lamontagne,Christophe Clement,Shevin T. Jacob,Lewis Rubinson,Abel Vanderschuren,Jan Hajek,Srinivas Murthy,Mauricio Ferri,Ian Crozier,Elhadj Ibrahima,Marie-Claire Lamah,John S. Schieffelin,David M. Brett-Major,Daniel G. Bausch,Nikki Shindo,Adrienne K. Chan,Tim O'Dempsey,Sharmistha Mishra,Michael Jacobs,Stuart Dickson,G. Marshall Lyon,Robert A. Fowler,Robert A. Fowler +30 more
TL;DR: This experience emphasizes that, in addition to evaluating specific medical treatments, improving the global capacity to provide supportive critical care to patients with EVD may be the greatest opportunity to improve patient outcomes.